Efficacy, Self Clinical Trial
Official title:
Well-being of Shelter Guests in Vancouver
NCT number | NCT03524495 |
Other study ID # | H18-00047 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 5, 2018 |
Est. completion date | June 2019 |
This study will primarily investigate the impacts of a one-time unconditional cash transfer
on the well-being of recently homeless individuals.
Secondary research questions will examine the impact of personal coaching for cash recipients
and the impact of a workshop and coaching intervention for non-cash recipients.
Status | Recruiting |
Enrollment | 125 |
Est. completion date | June 2019 |
Est. primary completion date | August 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Age - Participants must be between the ages of 19 and 65 - Length of Time Homeless - Participants must be homeless for two calendar years or less. - Employability - Project participants must be able / eligible to gain full-time employment in the near future (i.e., Canadian citizen or permanent resident) Exclusion Criteria: - Severity of Substance Use - Participants scoring = 6 on the Drug Abuse Screening Test (DAST-10) will be excluded. - Severity of Alcohol Use - Participants scoring within the problematic range (i.e., = 20) on the Alcohol Use Disorders Identification Test (AUDIT) will be excluded. - Severity of Psychiatric Symptoms -Participants scoring = 3 on item 5, or scoring > 4 on items 13 or 14 of the Colorado Symptom Index (CSI) will be excluded. - Participants will be excluded if they indicate that receiving a lump sum of around $8000 would have negative impacts on their life. |
Country | Name | City | State |
---|---|---|---|
Canada | New Leaf Project | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia | Government of Canada, Mitacs, New Leaf Project, U.S. National Science Foundation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Satisfaction with Life | Satisfaction with Life will be measured using the 5-item Satisfaction with Life Scale. Items will be rated on a Likert scale from 1 (Strongly disagree) to 7 (Strongly agree). The items will be averaged to form a composite score. Multiple imputation will be used to account for missing data. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Positive Affect | Positive affect will be measured using the 6 positive emotions from the 12-item Schedule of Positive and Negative Experience Scale. Items will be rated on a Likert scale from 1 (Very rarely or never) to 5 (Very often or always). The items will be averaged to form a composite score. Multiple imputation will be used to account for missing data. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Negative Affect | Negative affect will be measured using the 6 negative emotions from the 12-item Schedule of Positive and Negative Experience Scale. Items will be rated on a Likert scale from 1 (Very rarely or never) to 5 (Very often or always). The items will be averaged to form a composite score. Multiple imputation will be used to account for missing data. Lower scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Subjective Well-being | A composite score will be computed by first standardizing scores of satisfaction with life, positive affect, and negative affect (reverse-coded), and then averaging these three standardized scores for each participant. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Fluid Intelligence | Fluid intelligence will be measured using 10 Raven's Standard Progressive Matrices. The accuracy (the number of items answered correctly divided by the total number of items) is the primary measurement. Items that are skipped or declined will be treated as incorrect answers. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Executive Function (accuracy) | Executive function will be measured using 12 trials of a visual Stroop task. Participants will be asked to click a button on the same side of the screen when image A appears, but the opposite side of the screen when image B appears. There are 6 congruent trials and 6 incongruent trials. Trials will be presented in random order. Executive function will be assessed in two ways. The first measure is accuracy (the number of items answered correctly divided by the total number of items). Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Executive Function (efficiency) | Executive function will be measured using 12 trials of a visual Stroop task. Participants will be asked to click a button on the same side of the screen when image A appears, but the opposite side of the screen when image B appears. There are 6 congruent trials and 6 incongruent trials. Trials will be presented in random order. Executive function will be assessed in two ways. The second measure is an efficiency score (the accuracy divided by the mean reaction time (RT) of correct trials). We will remove the participant if their mean RT is 3 standard deviations away from the mean RT of the sample at that time point. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month | |
Primary | Self-efficacy | Self-efficacy will be measured using the 10-item General Self-Efficacy Scale. Items will be rated on a Likert scale from 1 (Not at all true) to 4 (Exactly true). The items will be averaged to form a composite score. Multiple imputation will be used to account for missing data. Higher scores indicate a better outcome. This measure will be assessed at each time point during the study, but confirmatory analyses will only be conducted from Baseline to 1-month. Analyses conducted at other time points will be considered exploratory. |
Baseline to 1-month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04301206 -
Videos and Simple Text to Empower Parents to Handle Their Sick Children
|
N/A | |
Recruiting |
NCT05517291 -
DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease
|
N/A | |
Recruiting |
NCT05803213 -
Learning Efficacy and Motivation of Medical Students in Clinical Training With Virtual Reality
|
N/A | |
Completed |
NCT06223412 -
Visual Based Program and Climate Change
|
N/A | |
Completed |
NCT05786638 -
Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma
|
N/A | |
Active, not recruiting |
NCT04690725 -
TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss
|
Phase 1/Phase 2 | |
Recruiting |
NCT05583006 -
Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
|
||
Not yet recruiting |
NCT03733652 -
Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients
|
N/A | |
Recruiting |
NCT04998721 -
A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care
|
Phase 2 | |
Recruiting |
NCT06288165 -
Lower Silesia Sinus Reducer Registry
|
||
Active, not recruiting |
NCT05842083 -
On-site Supportive Communication Training in Doctor-patient Communication
|
N/A | |
Recruiting |
NCT06451146 -
Lower Silesian Orbital Atherectomy Registry (LOAR)
|
||
Recruiting |
NCT05916898 -
The Lower Silesia Shockwave Registry
|
||
Completed |
NCT04561466 -
Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
|
Phase 2/Phase 3 | |
Completed |
NCT04341714 -
Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic
|
||
Recruiting |
NCT04541524 -
Vienna Preserflo Cohort Study
|
||
Recruiting |
NCT05825729 -
Diagnostic Efficacy Of 3 EUS-FNB Techniques
|
Phase 4 | |
Completed |
NCT03750877 -
Median and Paramedian Approach in Spinal Anesthesia
|
N/A | |
Completed |
NCT05141929 -
Effect of Web-Based Education on Gestational Diabetes Mellitus and Health Management Self Efficacy
|
N/A | |
Recruiting |
NCT03220919 -
Efficacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 Diabetes
|
N/A |